Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Michael Jon Szarek

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Szarek, Michael

One or more keywords matched the following items that are connected to Szarek, Michael

Item Type	Name
Academic Article	High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Academic Article	Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Academic Article	High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Concept	Apolipoprotein A-I
Concept	Apolipoproteins E
Concept	Apolipoprotein B-100
Concept	Apolipoproteins
Concept	Apolipoproteins B
Academic Article	Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
Academic Article	HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
Academic Article	Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
Academic Article	Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
Academic Article	LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.
Academic Article	Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.

Search Criteria

Apolipoproteins